The article says:
"With the funding of clinical research, the research can be started within a year. The first target is androgenetic alopecia, whose mechanism is clear, and the period will be about one and a half years."
Once funded human studies can start within 1 year and then the treatment can go to market after 1 1/2 years. This means it should go to market approx 2 1/2 years after they get the necessary funding. If they got the necessary funding today it should hit the market in 2023.
Blind speculator here, the answer is no. The prices they wanted to charge are insane and anyone with money probably realizes that there is no profit long term for this, as they will eventually be beaten by a competitor seeing that 4-5 companies are now roughly in the same spot (that we know of, maybe more like L'oreal behind close doors).No chance anybody here knows. This question just leads to blind speculation.